FBLG
FibroBiologics·NASDAQ
--
--(--)
--
--(--)
FBLG fundamentals
FibroBiologics (FBLG) released its earnings on Jul 31, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.12 (YoY -500.00%), met estimates.
Revenue / YoY
0
--
EPS / YoY
-0.12
-500.00%
Report date
Jul 31, 2025
EPS
Actual | 0.03 | -0.09 | -0.14 | -0.12 |
Forecast | 0.03 | -0.092 | -0.125 | -0.12 |
Surprise | 0.00% | +2.17% | -12.00% | 0.00% |
Revenue
Actual | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What guidance did FibroBiologics's management provide for the next earnings period?What does FibroBiologics do and what are its main business segments?What were the key takeaways from FibroBiologics's earnings call?What is FibroBiologics's latest dividend and current dividend yield?What is FibroBiologics's gross profit margin?What is the revenue and EPS growth rate for FibroBiologics year over year?Did FibroBiologics beat or miss consensus estimates last quarter?What were the key takeaways from FibroBiologics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
